Relay Therapeutics, Inc. (RLAY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.45B |
| Enterprise Value | 1.4B |
| P/E Ratio | -13.06 |
| PEG Ratio | -0.87 |
| Price/Sales Ratio | 421 |
| Price/Book Ratio | 5.28 |
| Enterprise/Revenue | 411.61 |
| Enterprise/EBITDA | -14.6 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -28.37 |
| Operating Margin | -30.95 |
| Return On Assets | -0.33 |
| Return On Equity | -0.4 |
| Revenue | 15.36M |
| Revenue/Share | 0.05 |
| Gross Profit | 11.8M |
| EBITDA | -272.92M |
| Net Income | -276.48M |
| Diluted EPS | -1.61 |
| Total Cash | 848.64M |
| Total Cash/Share | 3.87 |
| Total Debt | 27.03M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 14.62 |
| Book Value Per Share | 3.74 |
| 52-Week Change | 213.51 |
| 52-Week High | 21.27 |
| 52-Week Low | 6.04 |
| Moving Average 50 Days | 18.38 |
| Moving Average 200 Days | 15.38 |
| Average Volume | 2.9M |
| Shares Outstanding | 220.96M |
| % Held by Institutions | 122.41 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |